Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

Clinical trial NCT01351025 · COMPLETED

Trial details

NCT number: NCT01351025
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2011-04-14
Primary completion: 2014-05-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.